PT3524601T - Solvato de dimetilsulfóxido de n-{3-[3-ciclopropil-5-(2-fluoro-4-iodofenilamino)-6,8-dimetil-2,4,7-trioxo-3,4,6,7-tetra-hidro-2h-pirido[4,3-d]pirimidin-1-il]-fenil}-ciclopropanocarboxamida como um inibidor de mek1/2 - Google Patents

Solvato de dimetilsulfóxido de n-{3-[3-ciclopropil-5-(2-fluoro-4-iodofenilamino)-6,8-dimetil-2,4,7-trioxo-3,4,6,7-tetra-hidro-2h-pirido[4,3-d]pirimidin-1-il]-fenil}-ciclopropanocarboxamida como um inibidor de mek1/2

Info

Publication number
PT3524601T
PT3524601T PT169187630T PT16918763T PT3524601T PT 3524601 T PT3524601 T PT 3524601T PT 169187630 T PT169187630 T PT 169187630T PT 16918763 T PT16918763 T PT 16918763T PT 3524601 T PT3524601 T PT 3524601T
Authority
PT
Portugal
Prior art keywords
dimethyl
iodophenylamino
trioxo
mek1
pyrido
Prior art date
Application number
PT169187630T
Other languages
English (en)
Portuguese (pt)
Original Assignee
R Pharm Joint Stock Company R Pharm Jsc
Alexey Evgenievich Repik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Pharm Joint Stock Company R Pharm Jsc, Alexey Evgenievich Repik filed Critical R Pharm Joint Stock Company R Pharm Jsc
Publication of PT3524601T publication Critical patent/PT3524601T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT169187630T 2016-10-10 2016-12-12 Solvato de dimetilsulfóxido de n-{3-[3-ciclopropil-5-(2-fluoro-4-iodofenilamino)-6,8-dimetil-2,4,7-trioxo-3,4,6,7-tetra-hidro-2h-pirido[4,3-d]pirimidin-1-il]-fenil}-ciclopropanocarboxamida como um inibidor de mek1/2 PT3524601T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2016139641A RU2627692C1 (ru) 2016-10-10 2016-10-10 N-{ 3-[3-циклопропил-5-(2-фторо-4-иодофениламино)-6,8-диметил-2,4,7-триоксо-3,4,6,7-тетрагидро-2Н-пиридо[4,3-d]пиримидин-1-ил]-фенил} -циклопропанкарбоксамида диметилсульфоксида сольват в качестве ингибитора МЕК1/2

Publications (1)

Publication Number Publication Date
PT3524601T true PT3524601T (pt) 2021-11-03

Family

ID=59641667

Family Applications (1)

Application Number Title Priority Date Filing Date
PT169187630T PT3524601T (pt) 2016-10-10 2016-12-12 Solvato de dimetilsulfóxido de n-{3-[3-ciclopropil-5-(2-fluoro-4-iodofenilamino)-6,8-dimetil-2,4,7-trioxo-3,4,6,7-tetra-hidro-2h-pirido[4,3-d]pirimidin-1-il]-fenil}-ciclopropanocarboxamida como um inibidor de mek1/2

Country Status (28)

Country Link
US (1) US10738049B2 (pl)
EP (1) EP3524601B1 (pl)
JP (1) JP6909299B2 (pl)
KR (1) KR102387288B1 (pl)
CN (1) CN110012668B (pl)
AU (1) AU2016426350B2 (pl)
BR (1) BR112019007223A2 (pl)
CA (1) CA3039524A1 (pl)
CO (1) CO2019004688A2 (pl)
CY (1) CY1125283T1 (pl)
DK (1) DK3524601T3 (pl)
EA (1) EA037939B1 (pl)
ES (1) ES2898026T3 (pl)
HR (1) HRP20211693T1 (pl)
HU (1) HUE056490T2 (pl)
LT (1) LT3524601T (pl)
MA (1) MA46440B1 (pl)
MD (1) MD3524601T2 (pl)
MX (1) MX388031B (pl)
PH (1) PH12019500721A1 (pl)
PL (1) PL3524601T3 (pl)
PT (1) PT3524601T (pl)
RS (1) RS62604B1 (pl)
RU (1) RU2627692C1 (pl)
SI (1) SI3524601T1 (pl)
SM (1) SMT202100633T1 (pl)
WO (1) WO2018070900A1 (pl)
ZA (1) ZA201902861B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025508195A (ja) * 2022-03-17 2025-03-21 スプリングワークス、セラピューティクス、インコーポレイテッド 小児患者における神経線維腫症１型（ｎｆ１）に関連する叢状神経線維腫（ｐｎ）のミルダメチニブによる治療
CN114853754B (zh) 2022-05-23 2023-04-18 云白药征武科技(上海)有限公司 一种硫代酰胺衍生物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2298768E (pt) * 2004-06-11 2012-12-05 Japan Tobacco Inc Derivados de 5-amino-2,4,7-trioxo-3,4,7,8-tetra-hidro-2hpirido[ 2,3-d]pirimidina e compostos relacionados para o tratamento do cancro
US7378423B2 (en) * 2004-06-11 2008-05-27 Japan Tobacco Inc. Pyrimidine compound and medical use thereof
TWI505828B (zh) * 2010-12-20 2015-11-01 葛蘭素史克智慧財產（第二）有限公司 新穎醫藥組成物
BR112015009134A2 (pt) * 2012-10-25 2017-07-04 Glaxosmithkline Llc combinação
RU2605400C1 (ru) * 2015-11-13 2016-12-20 ЗАО "Р-Фарм" ПРОИЗВОДНЫЕ 1-(3-АМИНОФЕНИЛ)-6,8-ДИМЕТИЛ-5-(4-ИОД-2-ФТОР-ФЕНИЛАМИНО)-3-ЦИКЛОПРОПИЛ-1H,6H-ПИРИДО[4,3-d]ПИРИМИДИН-2,4,7-ТРИОНА В КАЧЕСТВЕ ИНГИБИТОРОВ МЕК1/2

Also Published As

Publication number Publication date
EP3524601A1 (en) 2019-08-14
KR20190062512A (ko) 2019-06-05
BR112019007223A2 (pt) 2019-07-02
CA3039524A1 (en) 2018-04-19
MA46440B1 (fr) 2021-11-30
AU2016426350B2 (en) 2020-08-27
MX388031B (es) 2025-03-19
EA037939B1 (ru) 2021-06-09
MD3524601T2 (ro) 2022-02-28
PL3524601T3 (pl) 2022-03-21
EA201900158A1 (ru) 2019-08-30
US10738049B2 (en) 2020-08-11
ES2898026T3 (es) 2022-03-03
MA46440A (fr) 2021-06-02
LT3524601T (lt) 2021-12-27
SI3524601T1 (sl) 2022-02-28
RU2627692C1 (ru) 2017-08-10
CY1125283T1 (el) 2023-03-24
DK3524601T3 (da) 2021-11-08
CN110012668B (zh) 2021-11-26
AU2016426350A1 (en) 2019-05-30
HRP20211693T1 (hr) 2022-02-04
JP2019531350A (ja) 2019-10-31
CO2019004688A2 (es) 2019-05-21
JP6909299B2 (ja) 2021-07-28
WO2018070900A1 (ru) 2018-04-19
US20190233415A1 (en) 2019-08-01
MX2019004137A (es) 2019-09-26
HUE056490T2 (hu) 2022-02-28
SMT202100633T1 (it) 2022-01-10
KR102387288B1 (ko) 2022-04-14
ZA201902861B (en) 2021-06-30
EP3524601A4 (en) 2020-03-11
PH12019500721A1 (en) 2019-12-02
CN110012668A (zh) 2019-07-12
EP3524601B1 (en) 2021-10-13
RS62604B1 (sr) 2021-12-31

Similar Documents

Publication Publication Date Title
IL258001B (en) Wireless charging platforms using three-dimensional phase coil arrays
IL261885A (en) Pyrazolopyrimidine history
HUE051492T2 (hu) Padlólapok elõállítására szolgáló eljárás
GB2542342B (en) Collapsible gym equipment
SI3478681T1 (sl) 1h-pirazolo(4,3-b)piridini kot inhibitorji pde1
GB201709985D0 (en) Tire monitor
PL3079382T3 (pl) Sposób wykonywania pomiarów MDT
IL254512A0 (en) Test pieces of real material for training explosive detection dogs
ZA201705740B (en) Space-saving exercise equipment
ZA201902861B (en) N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2h-pyrido[4,3-d]pyrimidin-1-yl]-phenyl}-cyclopropanecarboxamide dimethyl sulphoxide solvate as an mek1/2 inhibitor
PL3156383T3 (pl) Sposób wytwarzania pianki nieorganicznej
GB201513154D0 (en) Hole forming tool
ZA201508182B (en) Floor member with foam core
IL254352A0 (en) Antenna for otolaryngology
GB201613159D0 (en) Golfing equipment
IL265318B (en) Antenna selection method
EP3261735A4 (en) Training equipment comprising harness for ball training
SG11201701637YA (en) A tetrahydropyrrolo[3,4-d][1,3]thiazine-derivative as bace inhibitor
GB2554423B (en) Exercise equipment
IL279375A (en) Multifunctional dynamic training bench
GB201710865D0 (en) Rolling pin apparatus
GB201715792D0 (en) Three dimensional printing equipment
GB201718639D0 (en) Golfing equipment
GB201518727D0 (en) A rapid universal immunodiagnositc test
GB2548880B (en) Sports equipment